Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy

References

• Derrien T, Guigo R, Johnson R. The long non-coding RNAs: a new player in the “dark matter”. Front Genet. 2011;2:107.
   PubMedGoogle Scholar
• Melissari MT, Grote P. Roles for long non-coding RNAs in physiology and disease. Pflugers Arch. 2016;468(6):945–958. doi:10.1007/s00424-016-1804-y
   PubMed Web of Science ®Google Scholar
• Dey BK, Mueller AC, Dutta A. Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014;5(4):e944014. doi:10.4161/21541272.2014.944014
   PubMedGoogle Scholar
• Luo L, Ji LD, Cai JJ, et al. Microarray analysis of long noncoding RNAs in female diabetic peripheral neuropathy patients. Cell Physiol Biochem. 2018;46(3):1209–1217. doi:10.1159/000489071
   PubMedGoogle Scholar
• Du H, Liu Z, Tan X, Ma Y, Gong Q. Identification of the genome-wide expression patterns of long non-coding RNAs and mRNAs in mice with streptozotocin-induced diabetic neuropathic pain. Neuroscience. 2019;15(402):90–103. doi:10.1016/j.neuroscience.2018.12.040
   Google Scholar
• Said G, Baudoin D, Toyooka K. Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy. J Neurol. 2008;255(11):1693–1702. doi:10.1007/s00415-008-0999-z
   PubMedGoogle Scholar
• El Boghdady NA, Badr GA. Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy. Cell Biochem Funct. 2012;30(4):328–334. doi:10.1002/cbf.2808
   PubMedGoogle Scholar
• Tavakkoly-Bazzaz J, Amoli MM, Pravica V, et al. VEGF gene polymorphism association with diabetic neuropathy. Mol Biol Rep. 2008;255(11):1693–1702. doi:10.1007/s11033-010-0013-6
   Google Scholar
• Feldman EL, Nave KA, Jensen TS, Bennett DL. New Horizons in Diabetic Neuropathy: mechanisms, Bioenergetics, and Pain. Neuron. 2017;93(6):1296–1313. doi:10.1016/j.neuron.2017.02.005
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–350. doi:10.1056/NEJMoa032782
   PubMed Web of Science ®Google Scholar
• Politi C, Ciccacci C, D’Amato C, et al. Recent advances in exploring the genetic susceptibility to diabetic neuropathy. Diabetes Res Clin Pract. 2016;120:198–208. doi:10.1016/j.diabres.2016.08.006
   PubMed Web of Science ®Google Scholar
• Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care. 2009;3(2):136–143. doi:10.1097/SPC.0b013e32832b7df5
   PubMedGoogle Scholar
• Boulton A, Tesfaye S. Diabetic Neuropathy - ODL Oxford Diabetes Library. Oxford University Press; 2010.
   Google Scholar
• Modarresi F, Faghihi MA, Patel NS, Sahagan BG, Wahlestedt C, Lopez-Toledano MA. Knockdown of BACE1-AS nonprotein-coding transcript modulates beta-amyloid-related hippocampal neurogenesis. Int J Alzheimers Dis. 2011;2011:929042.
   PubMedGoogle Scholar
• Magistri M, Faghihi MA, St Laurent G, Wahlestedt C. Regulation of chromatin structure by long non-coding RNAs: focus on natural antisense transcripts. Trends Genet. 2012;28(8):389–396. doi:10.1016/j.tig.2012.03.013
   PubMed Web of Science ®Google Scholar
• Knauss JL, Sun T. Regulatory mechanisms of long non-coding RNAs in vertebrate central nervous system development and function. Neuroscience. 2013;235:200–214. doi:10.1016/j.neuroscience.2013.01.022
   PubMed Web of Science ®Google Scholar
• Khorkova O, Hsiao J, Wahlestedt C. Basic biology and therapeutic implications of lncRNA. Adv Drug Deliv Rev. 2015;87:15–24. doi:10.1016/j.addr.2015.05.012
   PubMed Web of Science ®Google Scholar
• Li G, Sheng X, Xu Y, et al. Co-expression changes of lncRNAs and mRNAs in the cervical sympathetic ganglia in diabetic cardiac autonomic neuropathic rats. J Neurosci Res. 2017;95(8):1690–1699. doi:10.1002/jnr.24000
   PubMedGoogle Scholar
• Stucky CL, Dubin AE, Jeske NA, Malin SA, McKemy DD, Story GM. Roles of transient receptor potential channels in pain. Brain Res Rev. 2009;60(1):2–23. doi:10.1016/j.brainresrev.2008.12.018
   PubMed Web of Science ®Google Scholar
• Brito R, Sheth S, Mukherjea D, Rybak L, Ramkumar V. TRPV1: a potential drug target for treating various diseases. Cells. 2014;3(2):517–545. doi:10.3390/cells3020517
   PubMedGoogle Scholar
• Marche P, Dubois S, Abraham P, et al. Neurovascular microcirculatory vasodilation mediated by C-fibers and Transient receptor potential vanilloid-type-1 channels (TRPV 1) is impaired in type 1 diabetes. Sci Rep. 2017;7(1):44322. doi:10.1038/srep44322
   PubMedGoogle Scholar
• Aaron M, Andrew S, Durga M. Nociceptive TRP channels: sensory detectors and transducers in multiple pain pathologies. Pharmaceuticals. 2016;9(4):72.
   Google Scholar
• Liu C, Li C, Deng Z, Du E, Xu C. Long non-coding RNA BC168687 is involved in TRPV1-mediated diabetic neuropathic pain in rats. Neuroscience. 2018;15(374):214–222. doi:10.1016/j.neuroscience.2018.01.049
   Google Scholar
• Hensellek S, Brell P, Schaible HG, Bräuer R, Banchet GSV. The cytokine TNF-α increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol Cell Neurosci. 2007;36(3):381–391. doi:10.1016/j.mcn.2007.07.010
   PubMed Web of Science ®Google Scholar
• Liu C, Tao J, Wu H, et al. Effects of LncRNA BC168687 siRNA on diabetic neuropathic pain mediated by P2X(7) Receptor on SGCs in DRG of rats. Biomed Res Int. 2017;7831251. doi:10.1155/2017/7831251
   PubMedGoogle Scholar
• Wang S, Xu H, Zou L, et al. LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia. Purinergic Signal. 2016;12(1):139–148. doi:10.1007/s11302-015-9488-x
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic receptors and pain. Curr Pharm Des. 2009;15(15):1717–1735. doi:10.2174/138161209788186335
   PubMed Web of Science ®Google Scholar
• Burnstock G. Purinergic signalling: from discovery to current developments. Exp Physiol. 2014;99(1):16–34.
   PubMed Web of Science ®Google Scholar
• Liang S, Xu C, Li G, Gao Y. P2X receptors and modulation of pain transmission: focus on effects of drugs and compounds used in traditional Chinese medicine. Neurochem Int. 2010;57(7):705–712. doi:10.1016/j.neuint.2010.09.004
   PubMedGoogle Scholar
• Kong F, Liu S, Xu C, et al. Electrophysiological studies of upregulated P2X7 receptors in rat superior cervical ganglia after myocardial ischemic injury. Neurochem Int. 2013;63(3):230–237. doi:10.1016/j.neuint.2013.06.003
   PubMedGoogle Scholar
• Verrotti A, Prezioso G, Scattoni R, Chiarelli F. Autonomic neuropathy in diabetes mellitus. Front Endocrinol. 2014;5:205.
   PubMed Web of Science ®Google Scholar
• Wu B, Zhang C, Zou L, et al. LncRNA uc.48+ siRNA improved diabetic sympathetic neuropathy in type 2 diabetic rats mediated by P2X7 receptor in SCG. Auton Neurosci. 2016;197:14–18. doi:10.1016/j.autneu.2016.04.001
   PubMedGoogle Scholar
• Yu W, Zhao GQ, Cao RJ, Zhu ZH, Li K. LncRNA NONRATT021972 was associated with neuropathic pain scoring in patients with type 2 diabetes. Behav Neurol. 2017;2017:2941297. doi:10.1155/2017/2941297
   PubMed Web of Science ®Google Scholar
• Peng H, Zou L, Xie J, et al. lncRNA NONRATT021972 siRNA decreases diabetic neuropathic pain mediated by the p2x(3) receptor in dorsal root ganglia. Mol Neurobiol. 2017;54(1):511–523. doi:10.1007/s12035-015-9632-1
   PubMed Web of Science ®Google Scholar
• Xu H, He L, Liu C, et al. LncRNA NONRATT021972 siRNA attenuates P2X7 receptor expression and inflammatory cytokine production induced by combined high glucose and free fatty acids in PC12 cells. Purinergic Signal. 2016;12(2):259–268. doi:10.1007/s11302-016-9500-0
   PubMedGoogle Scholar
• Liu S, Zou L, Xie J, et al. LncRNA NONRATT021972 siRNA regulates neuropathic pain behaviors in type 2 diabetic rats through the P2X7 receptor in dorsal root ganglia. Mol Brain. 2016;23(9):44. doi:10.1186/s13041-016-0226-2
   Web of Science ®Google Scholar
• Li Z, Li X, Chen X, et al. Emerging roles of long non-coding RNAs in neuropathic pain. Cell Prolif. 2019;52(1):e12528. doi:10.1111/cpr.12528
   PubMed Web of Science ®Google Scholar
• Dou L, Lin H, Wang K, et al. Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155. Oncotarget. 2017;8(52):89949–89957. doi:10.18632/oncotarget.21192
   PubMedGoogle Scholar
• Dou L, Lin H, Wang K, et al. Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155. Oncotarget. 2017;8(52):89949. doi:10.18632/oncotarget.21192
   PubMedGoogle Scholar
• Zhao X, Tang Z, Zhang H, et al. A long non-coding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons. Nat Neurosci. 2013;16(8):1024–1031. doi:10.1038/nn.3438
   PubMed Web of Science ®Google Scholar
• Li G, Jiang H, Zheng C, et al. Long non-coding RNA MRAK009713 is a novel regulator of neuropathic pain in rats. Pain. 2017;158(10):2042–2052. doi:10.1097/j.pain.0000000000001013
   PubMedGoogle Scholar
• Zhao Y, Li S, Xia N, Shi Y, Zhao CM. Effects of XIST/miR-137 axis on neuropathic pain by targeting TNFAIP1 in a rat model. J Cell Physiol. 2018;233(5):4307–4316. doi:10.1002/jcp.26254
   PubMed Web of Science ®Google Scholar